Tech Company Financing Transactions
Afferent Pharmaceuticals Funding Round
Afferent Pharmaceuticals secured a $5 million funding round on 3/31/2012. Investors included Domain Associates, Third Rock Ventures and private investors.
Transaction Overview
Company Name
Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Domain Associates (Jesse Treu)
Third Rock Ventures (Kevin Starr)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2755 Campus Dr. 100
San Mateo, CA 94403
USA
San Mateo, CA 94403
USA
Phone
Website
Email Address
Not Recorded
Overview
A leader in the development of novel, selective small molecules that target the P2X3 purinergic receptor, for the treatment of a range of debilitating symptoms and sensory disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kathleen Glaub
Chief Medical Officer
Michael Kitt
Chief Scientific Officer
Anthony Ford
VP - Operations
Peter Butera
Browse more venture capital transactions:
Prev: 3/31/2012: Blueprint Labs venture capital transaction
Next: 3/31/2012: Advanced Electron Beams venture capital transaction
Share this article
News on VC Transactions
We do our best to document tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs